Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × Etoposide × Clear all

NCT04452370 2021-07-21

Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

Phase 2 Unknown

Triple Negative Breast Neoplasms